Business Description
![Athira Pharma Inc Athira Pharma Inc logo](https://static.gurufocus.com/logos/0C0000BYAZ.png?14)
Athira Pharma Inc
NAICS : 541714
SIC : 2833
ISIN : US04746L1044
Share Class Description:
ATHA: Ordinary SharesDescription
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 65.22 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -26.5 | |||||
3-Year EPS without NRI Growth Rate | -24.5 | |||||
3-Year FCF Growth Rate | -6.4 | |||||
3-Year Book Growth Rate | -26.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 22.27 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.33 | |||||
9-Day RSI | 47.7 | |||||
14-Day RSI | 49.7 | |||||
6-1 Month Momentum % | -14.25 | |||||
12-1 Month Momentum % | 32.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.97 | |||||
Quick Ratio | 3.97 | |||||
Cash Ratio | 3.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.5 | |||||
Shareholder Yield % | 0.28 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -85.95 | |||||
ROA % | -71.11 | |||||
ROIC % | -1116 | |||||
ROC (Joel Greenblatt) % | -2736.68 | |||||
ROCE % | -91.13 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.43 | |||||
Price-to-Tangible-Book | 1.53 | |||||
EV-to-EBIT | -0.24 | |||||
EV-to-EBITDA | -0.24 | |||||
EV-to-FCF | -0.29 | |||||
Price-to-Net-Current-Asset-Value | 1.62 | |||||
Price-to-Net-Cash | 2 | |||||
Earnings Yield (Greenblatt) % | -416.67 | |||||
FCF Yield % | -82.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ATHA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Athira Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.97 | ||
Beta | 2.85 | ||
Volatility % | 105.57 | ||
14-Day RSI | 49.7 | ||
14-Day ATR ($) | 0.228356 | ||
20-Day SMA ($) | 3.15225 | ||
12-1 Month Momentum % | 32.68 | ||
52-Week Range ($) | 1.33 - 4.2984 | ||
Shares Outstanding (Mil) | 38.44 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Athira Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Athira Pharma Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Athira Pharma Inc Frequently Asked Questions
What is Athira Pharma Inc(ATHA)'s stock price today?
The current price of ATHA is $3.32. The 52 week high of ATHA is $4.30 and 52 week low is $1.33.
When is next earnings date of Athira Pharma Inc(ATHA)?
The next earnings date of Athira Pharma Inc(ATHA) is 2024-11-08 Est..
Does Athira Pharma Inc(ATHA) pay dividends? If so, how much?
Athira Pharma Inc(ATHA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |